Diagnosis of neurological and non-neurological disorders via bimodal/multimodal imaging with lanthanide based nanoparticles
Coordination Chemistry Reviews,
Journal Year:
2025,
Volume and Issue:
532, P. 216527 - 216527
Published: Feb. 18, 2025
Language: Английский
Behavioral and pathological characteristics of 5xFAD female mice in the early stage
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Feb. 26, 2025
Alzheimer's
disease
(AD)
is
a
central
nervous
system
degenerative
with
insidious
onset
and
gradual
development
caused
by
selective
progressive
loss
of
neurons.
The
5xFAD
mouse
relatively
mature
model
AD.
However,
the
behavioral
research
on
female
more
focused
changes
late
memory
function,
exploration
its
early
pathological
still
incomplete.
This
aims
to
explore
in
emotional
function
(including
anxiety
depression),
motor
ability,
amyloid
plaques,
glial
cell
response
neurogenesis
hippocampus
mice
stage,
laying
foundation
for
comprehensive
mechanism
results
this
study
found
that
4-month-old
mainly
showed
decline
without
other
dysfunction.
Accompanied
large
amount
protein
plaques
deposited
hippocampus,
it
induced
microglia
astrocytes,
decreased
significantly
age,
especially
mice,
which
resulted
decrease
number
new
may
be
an
important
reason
stage.
Language: Английский
Competitive Electrochemical Immunosensor for Trace Phosphorylated Tau181 Analysis in Plasma: Toward Point-of-Care Technologies of Alzheimer’s Disease
Chencheng Luo,
No information about this author
Xiaoyu Zhu,
No information about this author
Yizhi Zhang
No information about this author
et al.
Talanta,
Journal Year:
2025,
Volume and Issue:
unknown, P. 128009 - 128009
Published: March 1, 2025
Language: Английский
Advancing Nanomaterial-Based Strategies for Alzheimer’s Disease: A Perspective
Hong Zhou,
No information about this author
Xiuhua Yin,
No information about this author
G. Y. Zhang
No information about this author
et al.
JACS Au,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 31, 2025
Alzheimer's
disease
(AD)
is
a
complex
neurodegenerative
disorder
and
the
most
common
cause
of
dementia.
By
2050,
number
AD
cases
projected
to
exceed
131
million,
placing
significant
strain
on
healthcare
systems
economies
worldwide.
The
pathogenesis
multifactorial,
involving
hypotheses/mechanisms,
such
as
amyloid-β
(Aβ)
plaques,
tau
protein
hyperphosphorylation,
cholinergic
neuron
damage,
oxidative
stress,
inflammation.
Despite
extensive
research,
complexity
these
potentially
entangled
mechanisms
has
hindered
development
treatments
that
can
reverse
progression.
Nanotechnology,
leveraging
unique
physical,
electrical,
magnetic,
optical
properties
nanomaterials,
emerged
promising
approach
for
treatment.
In
this
Perspective,
we
first
outlined
major
current
pathogenic
hypotheses
then
reviewed
recent
advances
in
nanomaterials
addressing
hypotheses.
We
have
also
discussed
challenges
translating
into
clinical
applications
proposed
future
directions,
particularly
multifunctional
multitarget
enhance
their
therapeutic
efficacy
applicability
Language: Английский